Endoglin: An 'Accessory' Receptor Regulating Blood Cell Development and Inflammation

Area of Science:

• Immunology
• Cell Biology
• Hematology

Background:

• Transforming growth factor-β1 (TGF-β1) signaling is crucial for cellular responses, including hematopoiesis.
• Endoglin (CD105) is an accessory receptor modulating TGF-β1 signaling, known for its role in endothelial cells and vascular diseases.
• Endoglin's expression on immune cells suggests a role in inflammation and immune cell development.

Purpose of the Study:

• To review current knowledge on Endoglin (CD105) expression and function in hematopoietic precursors and mature immune cells.
• To highlight Endoglin's potential role in immune cell maturation and function.
• To explore Endoglin's involvement in shaping innate and adaptive immune responses.

Main Methods:

• Literature review of studies on Endoglin (CD105) in hematopoiesis and immunology.
• Analysis of Endoglin expression patterns across various hematopoietic and immune cell lineages.
• Synthesis of findings regarding Endoglin's functional implications in immune processes.

Main Results:

• Endoglin (CD105) is expressed on hematopoietic progenitor/precursor cells and diverse mature immune cells (macrophages, mast cells, T-cells).
• Endoglin's differential expression during hematopoiesis suggests a role in lineage development.
• Evidence indicates Endoglin influences inflammatory processes and immune cell function.

Conclusions:

• Endoglin (CD105) plays a significant role beyond endothelial cells, impacting hematopoiesis and immune cell function.
• Further research into Endoglin's function in various immune subsets is warranted.
• Endoglin is implicated as a key factor in regulating immune responses and cell lineage development.